Ironwood Pharmaceuticals IRWD Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's other income (expense)?
- Ironwood Pharmaceuticals (IRWD) reported other income (expense) of -$7.4M in Q1 2026.
- How has Ironwood Pharmaceuticals's other income (expense) changed year-over-year?
- Ironwood Pharmaceuticals's other income (expense) decreased by 3.3% year-over-year, from -$7.16M to -$7.4M.
- What is the long-term trend for Ironwood Pharmaceuticals's other income (expense)?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's other income (expense) has grown at a -2.6% compound annual growth rate (CAGR), from -$31.6M to -$28.48M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.